A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Status:
Terminated
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and effectiveness of the study drug
known as LY3053102 in participants with Type 2 diabetes mellitus. The study drug will be
given in different doses as an injection under the skin. The study is expected to last up to
6 months for each participant. Participants may remain on stable-dose metformin as prescribed
by their personal physician.